Adherence to Mediterranean Lifestyle Linked to Lower Mortality
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 29, 2023 -- For middle-aged and older adults, higher adherence to the Mediterranean lifestyle is associated with lower all-cause and cancer mortality, according to a study published online Aug. 16 in Mayo Clinic Proceedings.
Javier Maroto-Rodriguez, from the Universidad Autónoma de Madrid, and colleagues examined the association between the Mediterranean lifestyle and all-cause, cancer, and cardiovascular disease (CVD) mortality among 110,799 individuals aged 40 to 75 years from the U.K. Biobank cohort. Mediterranean lifestyle was assessed at baseline using the Mediterranean Lifestyle (MEDLIFE) index and included three groups: Mediterranean food consumption, Mediterranean dietary habits, and physical activity, rest, social habits, and conviviality.
The researchers identified 4,247 total deaths, 2,401 cancer deaths, and 731 CVD deaths during a median follow-up of 9.4 years. For all-cause mortality, increasing quartiles of the MEDLIFE index had hazard ratios of 0.89, 0.81, and 0.71, respectively, compared with the first quartile. The quartiles had hazard ratios of 0.90, 0.83, and 0.72 for cancer mortality. Independent associations were seen for all MEDLIFE index blocks with a lower risk for all-cause and cancer death; physical activity, rest, social habits, and conviviality were linked to lower CVD mortality.
"This study suggests that it's possible for non-Mediterranean populations to adopt the Mediterranean diet using locally available products and to adopt the overall Mediterranean lifestyle within their own cultural contexts," coauthor Mercedes Sotos Prieto, Ph.D., also from Universidad Autónoma de Madrid, said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
Peanut Consumption Starting in Infancy Provides Lasting Tolerance
THURSDAY, May 30, 2024 -- Peanut consumption starting in infancy and continuing to age 5 years provides lasting tolerance into adolescence, according to a study published in the...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.